11-[(4-butyltriazol-1-yl)methyl]-3-phenyl-10-oxa-3-azatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-9-one
C24H24N4O2 — CID 165413945
Data last refreshed: (MolForge compound catalog, from PubChem)
About 11-[(4-butyltriazol-1-yl)methyl]-3-phenyl-10-oxa-3-azatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-9-one
11-[(4-butyltriazol-1-yl)methyl]-3-phenyl-10-oxa-3-azatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-9-one (PubChem CID 165413945) has the molecular formula C24H24N4O2 and a molecular weight of 400.48 g/mol. Its IUPAC name is 11-[(4-butyltriazol-1-yl)methyl]-3-phenyl-10-oxa-3-azatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-9-one.
Molecular Properties
| Compound Name | 11-[(4-butyltriazol-1-yl)methyl]-3-phenyl-10-oxa-3-azatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-9-one |
|---|---|
| PubChem CID | 165413945 |
| Molecular Formula | C24H24N4O2 |
| Molecular Weight | 400.48 g/mol |
| Exact Mass | 400.19 |
| IUPAC Name | 11-[(4-butyltriazol-1-yl)methyl]-3-phenyl-10-oxa-3-azatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-9-one |
| SMILES | CCCCc1cn(CC2Cc3cn(-c4ccccc4)c4cccc(c34)C(=O)O2)nn1 |
| InChI | InChI=1S/C24H24N4O2/c1-2-3-8-18-15-27(26-25-18)16-20-13-17-14-28(19-9-5-4-6-10-19)22-12-7-11-21(23(17)22)24(29)30-20/h4-7,9-12,14-15,20H,2-3,8,13,16H2,1H3 |
| InChIKey | DVSAAOQYLRZIGE-UHFFFAOYSA-N |
| XLogP | 4.35 |
| TPSA | 61.94 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 400.48 |
| LogP ≤ 5 | 4.35 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 165413945 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.